FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381805110> ?p ?o ?g. }

• W4381805110 abstract "Introduction: Non-alcoholic fatty liver disease (NAFLD) is one of the metabolic disorders related to the pathophysiology of type 2 diabetes mellitus (T2DM). Therapeutic strategies are focused on the improvement of energy balance and lifestyle modification. Additionally, the derivative of the bioactive fungal metabolite is of interest to provide health benefits, especially in obese and pre-diabetic conditions. In our screening of anti-diabetic compounds from fungal metabolites and semisynthetic derivatives, a depsidone derivative, namely pyridylnidulin (PN), showed potent glucose uptake-inducing activity. The present study aimed to investigate the liver lipid metabolism and anti-diabetic properties of PN in diet-induced obesity mice. Methods: Male C57BL/6 mice were induced obesity and pre-diabetic conditions by dietary intervention with a high-fat diet (HFD) for 6 weeks. These obese mice were orally administered with PN (40 or 120 mg/kg), metformin (150 mg/kg), or vehicle for 4 weeks. Glucose tolerance, plasma adipocytokines, hepatic gene and protein expressions were assessed after treatment. Results: Improved glucose tolerance and reduced fasting blood glucose levels were found in the PN and metformin-treated mice. Additionally, hepatic triglyceride levels were consistent with the histopathological steatosis score regarding hepatocellular hypertrophy in the PN and metformin groups. The levels of plasma adipocytokines such as tumor necrosis factor-α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) were reduced in the PN (120 mg/kg) and metformin-treated mice. In addition, hepatic gene expression involved in lipid metabolism, including lipogenic enzymes was significantly reduced in the PN (120 mg/kg) and metformin-treated mice. The increased protein expression levels of phosphorylated AMP-activated protein kinase (p-AMPK) was also found in PN and metformin-treated mice. Discussion: Considering the increased p-AMPK protein expression levels in PN and metformin-treated mice were revealed as the underlying mechanisms to improve metabolic parameters. These results suggested that PN provided the health benefit to slow the progression of NAFLD and T2DM in obese and pre-diabetic conditions." @default.
• W4381805110 created "2023-06-24" @default.
• W4381805110 creator A5003082556 @default.
• W4381805110 creator A5006468349 @default.
• W4381805110 creator A5017942364 @default.
• W4381805110 creator A5057830661 @default.
• W4381805110 creator A5063276893 @default.
• W4381805110 creator A5063822350 @default.
• W4381805110 creator A5090650539 @default.
• W4381805110 creator A5092248994 @default.
• W4381805110 creator A5092248995 @default.
• W4381805110 date "2023-06-22" @default.
• W4381805110 modified "2023-09-25" @default.
• W4381805110 title "Pyridylnidulin exerts anti-diabetic properties and improves non-alcoholic fatty liver disease in diet-induced obesity mice" @default.
• W4381805110 cites W1969161182 @default.
• W4381805110 cites W1981890453 @default.
• W4381805110 cites W1993456360 @default.
• W4381805110 cites W2031533316 @default.
• W4381805110 cites W2035498702 @default.
• W4381805110 cites W2040732264 @default.
• W4381805110 cites W2069038722 @default.
• W4381805110 cites W2080999576 @default.
• W4381805110 cites W2089567564 @default.
• W4381805110 cites W2109796699 @default.
• W4381805110 cites W2113653640 @default.
• W4381805110 cites W2118969396 @default.
• W4381805110 cites W2328589456 @default.
• W4381805110 cites W2398284807 @default.
• W4381805110 cites W2509220708 @default.
• W4381805110 cites W2558605920 @default.
• W4381805110 cites W2560347556 @default.
• W4381805110 cites W2598068944 @default.
• W4381805110 cites W2752428556 @default.
• W4381805110 cites W2753709051 @default.
• W4381805110 cites W2789155443 @default.
• W4381805110 cites W2810629608 @default.
• W4381805110 cites W2904492039 @default.
• W4381805110 cites W2910137233 @default.
• W4381805110 cites W2921967571 @default.
• W4381805110 cites W2957932790 @default.
• W4381805110 cites W2994834689 @default.
• W4381805110 cites W2996241811 @default.
• W4381805110 cites W3009785233 @default.
• W4381805110 cites W3016145305 @default.
• W4381805110 cites W3023841394 @default.
• W4381805110 cites W3135039241 @default.
• W4381805110 cites W3162357213 @default.
• W4381805110 cites W3194668723 @default.
• W4381805110 cites W4200530196 @default.
• W4381805110 cites W4224305572 @default.
• W4381805110 cites W4293103566 @default.
• W4381805110 cites W4324311167 @default.
• W4381805110 doi "https://doi.org/10.3389/fmolb.2023.1208215" @default.
• W4381805110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37426418" @default.
• W4381805110 hasPublicationYear "2023" @default.
• W4381805110 type Work @default.
• W4381805110 citedByCount "0" @default.
• W4381805110 crossrefType "journal-article" @default.
• W4381805110 hasAuthorship W4381805110A5003082556 @default.
• W4381805110 hasAuthorship W4381805110A5006468349 @default.
• W4381805110 hasAuthorship W4381805110A5017942364 @default.
• W4381805110 hasAuthorship W4381805110A5057830661 @default.
• W4381805110 hasAuthorship W4381805110A5063276893 @default.
• W4381805110 hasAuthorship W4381805110A5063822350 @default.
• W4381805110 hasAuthorship W4381805110A5090650539 @default.
• W4381805110 hasAuthorship W4381805110A5092248994 @default.
• W4381805110 hasAuthorship W4381805110A5092248995 @default.
• W4381805110 hasBestOaLocation W43818051101 @default.
• W4381805110 hasConcept C126322002 @default.
• W4381805110 hasConcept C134018914 @default.
• W4381805110 hasConcept C17093226 @default.
• W4381805110 hasConcept C194832188 @default.
• W4381805110 hasConcept C2776175330 @default.
• W4381805110 hasConcept C2777180221 @default.
• W4381805110 hasConcept C2777391703 @default.
• W4381805110 hasConcept C2778163477 @default.
• W4381805110 hasConcept C2778772119 @default.
• W4381805110 hasConcept C2778913445 @default.
• W4381805110 hasConcept C2779134260 @default.
• W4381805110 hasConcept C2780323712 @default.
• W4381805110 hasConcept C4733338 @default.
• W4381805110 hasConcept C555293320 @default.
• W4381805110 hasConcept C71924100 @default.
• W4381805110 hasConceptScore W4381805110C126322002 @default.
• W4381805110 hasConceptScore W4381805110C134018914 @default.
• W4381805110 hasConceptScore W4381805110C17093226 @default.
• W4381805110 hasConceptScore W4381805110C194832188 @default.
• W4381805110 hasConceptScore W4381805110C2776175330 @default.
• W4381805110 hasConceptScore W4381805110C2777180221 @default.
• W4381805110 hasConceptScore W4381805110C2777391703 @default.
• W4381805110 hasConceptScore W4381805110C2778163477 @default.
• W4381805110 hasConceptScore W4381805110C2778772119 @default.
• W4381805110 hasConceptScore W4381805110C2778913445 @default.
• W4381805110 hasConceptScore W4381805110C2779134260 @default.
• W4381805110 hasConceptScore W4381805110C2780323712 @default.
• W4381805110 hasConceptScore W4381805110C4733338 @default.
• W4381805110 hasConceptScore W4381805110C555293320 @default.
• W4381805110 hasConceptScore W4381805110C71924100 @default.
• W4381805110 hasFunder F4320322614 @default.
• W4381805110 hasFunder F4320335210 @default.

• next